# A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

> **NCT04135833** · PHASE1 · COMPLETED · sponsor: **Beta Pharma, Inc.** · enrollment: 31 (actual)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** BPI-7711
- **DRUG:** BPI-7711
- **DRUG:** Itraconazole
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT04135833
- **Lead sponsor:** Beta Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-12
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-07-22
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135833, "A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04135833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*